| CAT # | Igama lemveliso | Inkcazo |
| CPD101235 | i-diABZI STING agonist-1 trihydrochloride | I-diABZI STING i-agonist-1 (i-trihydrochloride) i-stimulator ekhethiweyo ye-interferon genes (STING) i-receptor agonist, kunye ne-EC50 ye-130, i-186 nM yomntu kunye nemouse, ngokulandelanayo. |
| CPD101234 | i-diABZI STING agonist-1 (Tautomerism) | I-diABZI STING i-agonist-1 I-Tautomerism (i-compound 3) i-stimulator ekhethiweyo ye-interferon genes (STING) i-receptor agonist, kunye ne-EC50s ye-130, i-186 nM yomntu kunye nemouse, ngokulandelanayo. |
| CPD101233 | i-diABZI STING agonist-1 | I-diABZI STING i-agonist-1 i-stimulator ekhethiweyo ye-interferon genes (STING) i-receptor agonist, kunye ne-EC50s ye-130, i-186 nM yomntu kunye nemouse, ngokulandelanayo. |
| CPD101232 | I-agonist ye-STING-4 | I-STING agonist-4 yi-stimulator ye-Interferon Genes (STING) i-receptor agonist ene-inhibitory constant ecacileyo (IC50) ye-20 nM. I-STING agonist-4 yi-symmetry enxulumene ne-amidobenzimidazole (ABZI)-enxulumene nekhompawundi esekwe ukwenza ii-ABZIs ezidityanisiweyo (diABZIs) kunye nokubophelela okuphuculweyo kwi-STING kunye nokusebenza kweselula. |
| CPD101231 | I-agonist ye-STING-3 | I-STING agonist-3, ekhutshwe kwi-patent WO2017175147A1 (umzekelo we-10), i-molecule ekhethiweyo kunye ne-non-nucleotide encinci ye-STING agonist kunye ne-peC50 kunye ne-pIC50 ye-7.5 kunye ne-9.5, ngokulandelanayo. I-STING agonist-3 inefuthe elihlala ixesha elide lokulwa ne-tumor kunye namandla amakhulu okuphucula unyango lomhlaza |
